Bristol Myers Squibb is a global biopharmaceutical company operating across more than 100 countries with 32,500 employees. Founded in 1887, it has evolved from its origins as Clinton Pharmaceutical Company into a major player in drug development and commercialisation, with particular strength in oncology, hematology, immunology, cardiology, and fibrosis.
The company's technical work spans cell therapy, immunotherapy, and other advanced modalities aimed at addressing serious diseases. Its scale and resources allow it to undertake large-scale clinical programmes whilst maintaining the capacity for scientific innovation across multiple therapeutic areas. The organisation maintains a global infrastructure for research, development, and distribution of biopharmaceuticals.
Bristol Myers Squibb combines the operational capabilities of an established pharmaceutical enterprise with structures designed to support innovation and scientific advancement. The company operates the Bristol Myers Squibb Foundation, which focuses on health equity and support for vulnerable populations worldwide.
